In the Clinical/Scientific Note "Dramatic rebounds of MS during pregnancy following fingolimod withdrawal” by G. Novi et al.,1 there is an error in the study funding statement, which should have specified, “Some of the results discussed in this publication were supported by Compagnia di San Paolo.” The authors regret the omission.
Reference
- 1.Novi G, Ghezzi A, Pizzorno M, et al. . Dramatic rebounds of MS during pregnancy following fingolimod withdrawal. Neurol Neuroimmunol Neuroinflamm 2017;4:e377. [DOI] [PMC free article] [PubMed] [Google Scholar]